Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APRE

Aprea Therapeutics Inc

May 08 • 04:00PM ET

0.9799

+0.0992 11.26 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: SLS BLRX APVO CUE IMNN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.97	Insider Own	12.76%	Shs Outstand	12.38M	Perf Week	19.79%
Market Cap	12.13M	Forward P/E	-	EPS next Y	-0.65	Insider Trans	3.96%	Shs Float	10.80M	Perf Month	33.50%
Enterprise Value	-1.74M	PEG	-	EPS next Q	-0.21	Inst Own	39.39%	Short Float	1.02%	Perf Quarter	42.01%
Income	-12.60M	P/S	41.83	EPS this Y	63.73%	Inst Trans	4.25%	Short Ratio	0.25	Perf Half Y	-25.31%
Sales	0.29M	P/B	0.65	EPS next Y	7.86%	ROA	-63.14%	Short Interest	0.11M	Perf YTD	14.88%
Book/sh	1.52	P/C	0.83	EPS next 5Y	27.68%	ROE	-74.58%	52W High	2.22 -55.86%	Perf Year	-40.75%
Cash/sh	1.18	P/FCF	-	EPS past 3/5Y	88.77% 47.99%	ROIC	-95.68%	52W Low	0.55 78.81%	Perf 3Y	-75.13%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	92.40%	Volatility	10.71% 11.46%	Perf 5Y	-98.86%
Dividend TTM	-	EV/Sales	-6.00	EPS Y/Y TTM	16.94%	Oper. Margin	-4631.12%	ATR (14)	0.09	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.63	Sales Y/Y TTM	-80.98%	Profit Margin	-4409.16%	RSI (14)	62.10	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.63	EPS Q/Q	34.29%	SMA20	10.08%	Beta	1.49	Target Price	4.55
Payout	-	Debt/Eq	0.00	Sales Q/Q	-98.38%	SMA50	19.39%	Rel Volume	2.23	Prev Close	0.88
Employees	8	LT Debt/Eq	0.00	Earnings	Mar 16 BMO	SMA200	-13.56%	Avg Volume	437.77K	Price	0.98
IPO	Oct 03, 2019	Option/Short	No / Yes	EPS/Sales Surpr.	17.95% -	Trades		Volume	974,529	Change	11.26%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)